Clinical trial Recruiting at 1 site Observational Ages 8 to 13

How common symptomatic gastroesophageal reflux is in Czech children aged 8–9 and 12–13

Official title: Prevalence of Symptomatic Gastroesophageal Reflux Disease in Children in the Czech Republic

Run by University Hospital, Motol · NCT07482969 · Data updated 2026-11-12

This project will see how common symptomatic GERD is in Czech children aged 8–9 and 12–13 by using school questionnaires and follow-up medical testing for kids who report reflux symptoms.

More Gastro Esophageal Reflux trials

Quick facts

Study typeObservational
Ages8 Years to 13 Years
SexAll
Enrollment1000 (estimated)
SponsorUniversity Hospital, Motol
Academic / other
Locations1 site (Prague)
StatusRecruiting
StartedDecember 20, 2025
Main results expectedDecember 30, 2028
Study endsDecember 30, 2028
Registry record updatedMarch 19, 2026
Trial IDNCT07482969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 8–9 or 12–13 who attend participating schools in the Czech Republic and can complete the web questionnaire and diagnostic testing, and who do not have psychomotor impairment, are the intended participants.

Probably not a fit

Children who are asymptomatic, live outside the Czech Republic, cannot travel to Prague for diagnostic testing, or have psychomotor impairment are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This population-based, cross-sectional study recruits children aged 8–9 and 12–13 through selected schools in the Czech Republic and begins with a secure web-based questionnaire about reflux symptoms and related factors. Children reporting heartburn (pyrosis) or regurgitation enter a stepwise diagnostic pathway starting with a standardized 14-day proton pump inhibitor (PPI) trial including 14 days of baseline symptom recording and 14 days on PPI at age-appropriate doses. Those without a clear response undergo upper endoscopy to look for esophagitis or complications, and if endoscopy is normal or inconclusive they receive 24-hour pH-impedance monitoring to quantify reflux and symptom association. Final classifications (confirmed GERD, reflux hypersensitivity, or functional pyrosis) are combined with validated quality-of-life measures to produce population prevalence estimates and explore symptom burden and risk factors.

Why it matters

Potential benefit: If successful, the study could clarify how many children have true GERD versus other causes of reflux symptoms, helping doctors target treatment and avoid unnecessary long-term PPI use.

How similar studies have gone: Similar population-based questionnaires combined with guideline-based diagnostic pathways have been used in other pediatric populations and produced credible prevalence data, so the approach is well-established though country-specific data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age group of 8 - 9 years and 12 - 13 years
* school attendance ability

Exclusion Criteria:

* psychomotor impairment

Where it's running

  • Motol University Hospital
    Prague, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Medical AI fine-tuning platform for major diseases

    This study tests a smart AI system that uses hospital data to help diagnose and guide care for patients with chronic gastritis, gastric cancer, reflux, coronary artery disease, or stroke.

    Recruiting Beijing Friendship Hospital · Beijing · NCT07795645

  • Nissen‑Sleeve versus Roux‑en‑Y gastric bypass for reflux in people with severe obesity

    This trial tests whether Nissen‑Sleeve gastrectomy or Roux‑en‑Y gastric bypass better controls GERD symptoms in adults who are eligible for bariatric surgery due to severe obesity.

    Recruiting Jagiellonian University · Krakow · NCT07158008

  • Breathing muscle training for gastroesophageal reflux (GERD)

    This trial will test whether a 3-month inspiratory muscle training program helps adults with GERD strengthen their breathing muscles and reduce reflux symptoms.

    Recruiting University of West Attica · Athens, Attica · NCT07131397

  • Evaluating hiatal closure for treating early GERD

    This study is testing if a new surgical method called hiatal closure can help people with early GERD feel better by fixing the problem with their esophagus.

    Recruiting University of Chicago · Chicago, Illinois · NCT06280664

  • Validation of a cough monitoring system

    This study is testing a new wearable device that tracks coughs in patients aged 2 and older to see if it can help doctors better understand and manage respiratory issues.

    Recruiting at 7 sites Cough Monitoring Medical Solutions · Alfena and 7 other locations · NCT05989698

  • Endoscopic anti-reflux treatment with APC for people with GERD

    This trial will test whether ARAT—an endoscopic anti-reflux procedure using argon plasma coagulation (APC)—can reduce chronic heartburn and acid reflux in adults who have a positive pH test and normal esophageal manometry.

    Recruiting Midwest Veterans' Biomedical Research Foundation · Kansas City, Missouri · NCT05570448

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.